Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Synthesis, antimicrobial and antiproliferative properties of epi-oligomycin A, the (33S)-diastereomer of oligomycin A.

Lysenkova LN, Saveljev OY, Omelchuk OA, Zatonsky GV, Korolev AM, Grammatikova NE, Bekker OB, Danilenko VN, Dezhenkova LG, Mavletova DA, Scherbakov AM, Shchekotikhin AE.

Nat Prod Res. 2019 May 10:1-9. doi: 10.1080/14786419.2019.1608540. [Epub ahead of print]

PMID:
31075992
2.

Draft Genome Sequence of Streptomyces xinghaiensis (fradiae) OlgR, a Strain Resistant to Oligomycin A.

Bekker OB, Vatlin AA, Zakharevich NV, Lysenkova LN, Shchekotikhin AE, Danilenko VN.

Microbiol Resour Announc. 2019 Jan 10;8(2). pii: e01531-18. doi: 10.1128/MRA.01531-18. eCollection 2019 Jan.

3.

A functional study of the global transcriptional regulator PadR from a strain Streptomyces fradiae-nitR+bld, resistant to nitrone-oligomycin.

Vatlin AA, Bekker OB, Lysenkova LN, Shchekotikhin AE, Danilenko VN.

J Basic Microbiol. 2018 Sep;58(9):739-746. doi: 10.1002/jobm.201800095. Epub 2018 Jul 2.

PMID:
29963725
4.

Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A.

Lysenkova LN, Saveljev OY, Grammatikova NE, Tsvetkov VB, Bekker OB, Danilenko VN, Dezhenkova LG, Bykov EE, Omelchuk OA, Korolev AM, Shchekotikhin AE.

J Antibiot (Tokyo). 2017 Jul;70(8):871-877. doi: 10.1038/ja.2017.48. Epub 2017 Apr 19.

PMID:
28420869
5.

[Sequencing and analysis of the resistome of Streptomyces fradiae ATCC19609 in order to develop a test system for screening of new antimicrobial agents].

Vatlin AA, Bekker OB, Lysenkova LN, Korolev AM, Shchekotikhin AE, Danilenko VN.

Genetika. 2016 Jun;52(6):723-7. Russian.

PMID:
29368834
6.

Draft Genome Sequence of Streptomyces fradiae olg1-1, a Strain Resistant to Nitrone-Oligomycin.

Vatlin AA, Bekker OB, Lysenkova LN, Danilenko VN.

Genome Announc. 2015 Oct 22;3(5). pii: e01252-15. doi: 10.1128/genomeA.01252-15.

7.

Study on retroaldol degradation products of antibiotic oligomycin A.

Lysenkova LN, Turchin KF, Korolev AM, Danilenko VN, Bekker OB, Dezhenkova LG, Shtil AA, Preobrazhenskaya MN.

J Antibiot (Tokyo). 2014 Feb;67(2):153-8. doi: 10.1038/ja.2013.92. Epub 2013 Oct 2.

PMID:
24084683
8.

Synthesis and cytotoxicity of oligomycin A derivatives modified in the side chain.

Lysenkova LN, Turchin KF, Korolev AM, Dezhenkova LG, Bekker OB, Shtil AA, Danilenko VN, Preobrazhenskaya MN.

Bioorg Med Chem. 2013 Jun 1;21(11):2918-24. doi: 10.1016/j.bmc.2013.03.081. Epub 2013 Apr 6.

PMID:
23623676
9.

A novel acyclic oligomycin A derivative formed via retro-aldol rearrangement of oligomycin A.

Lysenkova LN, Turchin KF, Korolev AM, Bykov EE, Danilenko VN, Bekker OB, Trenin AS, Elizarov SM, Dezhenkova LG, Shtil AA, Preobrazhenskaya MN.

J Antibiot (Tokyo). 2012 Aug;65(8):405-11. doi: 10.1038/ja.2012.38. Epub 2012 May 23.

PMID:
22617550
10.

Synthesis and properties of a novel brominated oligomycin A derivative.

Lysenkova LN, Turchin KF, Korolev AM, Danilenko VN, Bekker OB, Trenin AS, Shtil AA, Preobrazhenskaya MN.

J Antibiot (Tokyo). 2012 Apr;65(4):223-5. doi: 10.1038/ja.2012.4. Epub 2012 Feb 8. No abstract available.

PMID:
22318333
11.

The first examples of chemical modification of oligomycin A.

Lysenkova LN, Turchin KF, Danilenko VN, Korolev AM, Preobrazhenskaya MN.

J Antibiot (Tokyo). 2010 Jan;63(1):17-22. doi: 10.1038/ja.2009.112. Epub 2009 Nov 13.

PMID:
19911026
12.

Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches.

Pearlstein RA, Vaz RJ, Kang J, Chen XL, Preobrazhenskaya M, Shchekotikhin AE, Korolev AM, Lysenkova LN, Miroshnikova OV, Hendrix J, Rampe D.

Bioorg Med Chem Lett. 2003 May 19;13(10):1829-35.

PMID:
12729675
13.

The formation of 2-hydroxy-4-hydroxymethyl-3-(indol-3-yl)-cyclopent-2-enone derivatives from ascorbigens.

Korolev AM, Yudina LN, Rozhkov II, Lysenkova LN, Lazhko EI, Luzikov YN, Preobrazhenskaya MN.

Carbohydr Res. 2001 Feb 28;330(4):469-77.

PMID:
11269398
14.

[Induction of antibiotic production in inactive cultures of actinomycetes. Monensin production by a mutant strain 2608 EB-1].

Malkina ND, Lazhko EI, Lysenkova LN, Dudnik IuV.

Antibiot Khimioter. 1995 Oct;40(10):3-6. Russian.

PMID:
8660117
15.

[Induction of antibiotic formation by inactive cultures of actinomycetes. A mutant strain of Streptomyces helvaticus, a new producer of bruneomycin].

Malkina ND, Dudnik IuV, Lysenkova LN, Terekhova LP, Katrukha GS.

Antibiot Khimioter. 1995 Jun;40(6):3-6. Russian.

PMID:
8593091
16.

167-A, a new antibiotic produced by a mutant of an inactive wild strain of Amycolata autotrophica.

Malkina ND, Dudnik YV, Lysenkova LN, Lazhko EI, Galatenko OA, Katrukha GS.

J Antibiot (Tokyo). 1994 Mar;47(3):342-8.

17.

[Physicochemical properties of octamycin].

Lysenkova LN, Brazhnikova MG, Borisova VN, Aleksandrova LG, Rubasheva LM.

Antibiot Med Biotekhnol. 1986 Dec;31(12):897-9. Russian.

PMID:
3566219
18.

[Formation of a new polyene antibiotic octamycin by a culture of Actinoplanes ianthinogenes subsp. octamycini].

Lysenkova LN, Ol'khovatova OL, Malkina ND.

Antibiot Med Biotekhnol. 1986 Oct;31(10):741-3. Russian.

PMID:
3789684
19.

[Isolation and physicochemical study of the components of the new antibacterial antibiotic 2562].

Lysenkova LN, Brazhnikova MG, Borisova VN, Fedorova GB, Rubasheva LM.

Antibiotiki. 1980 Jul;25(7):483-8. Russian.

PMID:
6250459
20.

[Isolation and physicochemical properties of the components of the antitumor antibiotic 4041 formed by a culture of Actinoplanes ianthinogenes susp. octamycini subsp. nov].

Brazhnikova MG, Borisova VN, Lysenkova LN, Rubasheva LM, Fedorova GV.

Antibiotiki. 1979 Aug;24(8):582-5. Russian. No abstract available.

PMID:
485105

Supplemental Content

Loading ...
Support Center